Philadelphia Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Philadelphia Trust Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.54M	Sell	25,425 -1,000	-4%	-$58.3K	0.11%	98
2025 Q4	$1.43M	Hold	26,425	–	–	0.1%	102
2025 Q3	$1.19M	Hold	26,425	–	–	0.08%	110
2025 Q2	$1.22M	Sell	26,425 -25	-0.1%	-$1.23K	0.09%	108
2025 Q1	$1.61M	Hold	26,450	–	–	0.14%	90
2024 Q4	$1.5M	Hold	26,450	–	–	0.11%	99
2024 Q3	$1.37M	Sell	26,450 -600	-2%	-$28.1K	0.1%	105
2024 Q2	$1.12M	Sell	27,050 -2,597	-9%	-$116K	0.09%	108
2024 Q1	$1.61M	Sell	29,647 -500	-2%	-$25.5K	0.13%	91
2023 Q4	$1.55M	Sell	30,147 -300	-1%	-$15.7K	0.15%	95
2023 Q3	$1.77M	Sell	30,447 -10,424	-26%	-$639K	0.18%	92
2023 Q2	$2.61M	Sell	40,871 -1,651	-4%	-$111K	0.25%	85
2023 Q1	$2.95M	Sell	42,522 -190	-0.4%	-$13.4K	0.3%	79
2022 Q4	$3.07M	Sell	42,712 -30	-0.1%	-$2.26K	0.33%	76
2022 Q3	$3.04M	Buy	42,742 +662	+2%	+$48K	0.34%	67
2022 Q2	$3.24M	Hold	42,080	–	–	0.33%	69
2022 Q1	$3.07M	Buy	42,080 +1,536	+4%	+$103K	0.24%	82
2021 Q4	$2.53M	Sell	40,544 -6,950	-15%	-$408K	0.18%	84
2021 Q3	$2.81M	Sell	47,494 -6,221	-12%	-$410K	0.21%	80
2021 Q2	$3.59M	Sell	53,715 -111	-0.2%	-$7.24K	0.25%	76
2021 Q1	$3.4M	Sell	53,826 -2,300	-4%	-$143K	0.26%	74
2020 Q4	$3.48M	Buy	56,126 +275	+0.5%	+$16.9K	0.28%	70
2020 Q3	$3.37M	Buy	55,851 +65	+0.1%	+$3.91K	0.32%	60
2020 Q2	$3.28M	Buy	55,786 +3,042	+6%	+$182K	0.35%	59
2020 Q1	$2.94M	Sell	52,744 -2,320	-4%	-$142K	0.37%	56
2019 Q4	$3.54M	Buy	55,064 +12,815	+30%	+$734K	0.3%	74
2019 Q3	$2.14M	Buy	42,249 +4,000	+10%	+$188K	0.2%	82
2019 Q2	$1.74M	Buy	38,249 +650	+2%	+$30.3K	0.15%	95
2019 Q1	$1.79M	Buy	37,599 +17,000	+83%	+$847K	0.16%	89
2018 Q4	$1.07M	Sell	20,599 -3,147	-13%	-$169K	0.11%	98
2018 Q3	$1.47M	Buy	23,746 +1,936	+9%	+$115K	0.12%	99
2018 Q2	$1.21M	Sell	21,810 -2,505	-10%	-$135K	0.11%	104
2018 Q1	$1.54M	Buy	24,315 +120	+0.5%	+$7.72K	0.13%	101
2017 Q4	$1.48M	Sell	24,195 -110	-0.5%	-$6.88K	0.12%	108
2017 Q3	$1.55M	Buy	24,305 +2,555	+12%	+$149K	0.13%	106
2017 Q2	$1.21M	Buy	21,750 +875	+4%	+$47.6K	0.1%	114
2017 Q1	$1.14M	Sell	20,875 -49	-0.2%	-$2.69K	0.09%	115
2016 Q4	$1.22M	Buy	20,924 +1,500	+8%	+$82K	0.1%	113
2016 Q3	$1.05M	Sell	19,424 -450	-2%	-$28.9K	0.09%	119
2016 Q2	$1.46M	Hold	19,874	–	–	0.13%	97
2016 Q1	$1.27M	Sell	19,874 -490	-2%	-$30.9K	0.11%	95
2015 Q4	$1.36M	Buy	20,364 +100	+0.5%	+$6.61K	0.11%	95
2015 Q3	$1.2M	Buy	20,264 +18,912	+1,399%	+$1.2M	0.11%	94
2015 Q2	$20.3K	Sell	1,352 -18,962	-93%	-$1.25M	0.08%	112
2015 Q1	$1.31M	Sell	20,314 -50	-0.2%	-$3.13K	0.1%	105
2014 Q4	$1.2M	Buy	20,364 +345	+2%	+$19.5K	0.1%	94
2014 Q3	$1.02M	Sell	20,019 -73	-0.4%	-$3.65K	0.06%	104
2014 Q2	$975K	Buy	20,092 +53	+0.3%	+$2.61K	0.06%	102
2014 Q1	$1.04M	Buy	20,039 +1,100	+6%	+$58.5K	0.07%	106
2013 Q4	$1.01M	Buy	18,939 +770	+4%	+$39.2K	0.06%	111
2013 Q3	$841K	Hold	18,169	–	–	0.06%	112
2013 Q2	$812K	Buy	+18,169	New	+$789K	0.06%	112

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Philadelphia Trust Company's BMY Position: Q1 2026 in Review

Philadelphia Trust Company reduced its Bristol-Myers Squibb (BMY) stake by 3.8% in Q1 2026, selling an estimated $58.3K and leaving 25,425 shares worth $1.54M. The position accounts for 0.11% of the portfolio, ranked #98.

Philadelphia Trust Company first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.59M in Q2 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Philadelphia Trust Company held 25,425 shares of Bristol-Myers Squibb worth $1.54M as of Q1 2026.
Philadelphia Trust Company sold 1,000 Bristol-Myers Squibb shares in Q1 2026, an estimated $58.3K.
Bristol-Myers Squibb made up 0.11% of Philadelphia Trust Company's portfolio in Q1 2026, its #98 holding.
Philadelphia Trust Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Philadelphia Trust Company's Bristol-Myers Squibb position peaked at $3.59M in Q2 2021.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.